Dr Farhan Cyprian
Dr Farhan Cyprian is a Medical Doctor (MBBS) and Associate Professor of Immunology at the College of Medicine, Qatar University (CMED-QU). He integrates clinical training with translational immunology to advance understanding of host–pathogen interactions, immune dysregulation, and their implications for precision medicine and optimized healthcare outcomes in the Gulf Cooperation Council (GCC) region.
Dr Cyprian earned his PhD from the École Normale Supérieure de Lyon, with doctoral research conducted at the Institut Mérieux P4 facility, where he developed expertise in TGF-β–mediated modulation of T-cell responses using transgenic models. His MSc focused on transcriptomics and its application to cancer biology. His research program centers on T-cell–driven immunity in severe infectious diseases, including SARS-CoV-2, tuberculosis, and oncoviruses, and on how metabolic disorders prevalent in the GCC modulate immune pathways, disease severity, and immune evasion.
A defining aspect of Dr Cyprian’s work is the application of omics-based approaches—including transcriptomics and immune profiling—to COVID-19 and other infections, enabling patient stratification, biomarker discovery, and identification of molecular signatures associated with severe disease. These efforts directly support precision medicine frameworks aimed at tailoring preventive and therapeutic strategies to population-specific risk factors in the GCC. He currently leads and collaborates on projects developing nanoparticle-based mucosal vaccines for RSV, influenza, and SARS-CoV-2, integrating systems immunology with functional assays to translate mechanistic insights into targeted interventions.
Working with well-characterized clinical cohorts and experimental models, Dr Cyprian seeks to bridge laboratory discoveries and clinical implementation, contributing to evidence-based, precision-guided healthcare solutions for the region. He has authored over 60 peer-reviewed publications with more than 2,200 citations and, as a founding faculty member at CMED-QU, continues to build regional research capacity in immunology and infectious diseases while mentoring the next generation of clinician-scientists.
